|
Sue,
If you meet the admissibility criteria for the EAP (Expanded Acces Program) for Lapatinib (Tykerb)+Capectabine(Xeloda) you won't have to pay for the drugs. This is the rule for non approved drugs offered on a compassionate basis by the manufacturers (at least this is how it works in North America).
If you are interested in the EAP program for Tykerb these are the locations down under (more sites may be opening, check with Glaxosmith kline or Pharmanet which may be the operator of the program for GSK):
Lapatinib EAP Call Center, Herston, 4029, Australia; Recruiting
Nicole McCarthy 1-888-489-5372
Lapatinib EAP Call Center, North Sydney, 2060, Australia; Recruiting
Fran Boyle 1-888-489-5372
Lapatinib EAP Call Center, Geelong, 3220, Australia; Recruiting
Richard Bell 1-888-489-5372
Lapatinib EAP Call Center, Perth, 6000, Australia; Recruiting
Arlene Chan 1-888-489-5372
Lapatinib EAP Call Center, Wodonga, 3690, Australia; Recruiting
Craig Underhill 1-888-489-5372
Lapatinib EAP Call Center, Bedford Park, 5042, Australia; Recruiting
Christos Karapetis 1-888-489-5372
Lapatinib EAP Call Center, Kogarah, 2217, Australia; Recruiting
Jodi Lynch 1-888-489-5372<!-- / message -->
Pharmanet:
Suite 301
2 Lyon Park Road
North Ryde
New South Wales 2113
AUSTRALIA
Tel: 61 2 9900 1700
Fax: 61 2 9900 1799
|